Report
Luuk Van Beek

Growth normalizing after exceptional period

Azelis and IMCD are going through several quarters of negative organic growth, after an exceptionally strong streak of positive growthWe believe the structural growth drivers are intact, and margins will remain resilient, but we modestly trim our estimates to reflect a larger than expected impact of destockingWe cut our TP for Azelis from EUR 28 to EUR 25 (13% upside) and for IMCD from EUR 170 to EUR 135 (40% upside). We upgrade Azelis from Hold to Buy and remain on Hold for IMCD. Dip in growth after high-growth period, recovery from 2024 onwardsAfter 6 quarters of stellar performance, organic growth
Provider
Degroof Petercam
Degroof Petercam

​We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

Analysts
Luuk Van Beek

Other Reports from Degroof Petercam

ResearchPool Subscriptions

Get the most out of your insights

Get in touch